We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,055 hedge funds and large institutions have $51.5B invested in Thermo Fisher Scientific in 2016 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 384 increasing their positions, 421 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 38

34% more call options, than puts

Call options by funds: $233M | Put options by funds: $174M

5% more capital invested

Capital invested by funds: $48.9B → $51.5B (+$2.6B)

3% more funds holding

Funds holding: 1,0241,055 (+31)

1% more funds holding in top 10

Funds holding in top 10: 7778 (+1)

9% less repeat investments, than reductions

Existing positions increased: 384 | Existing positions reduced: 421

2.57% less ownership

Funds ownership: 91.36%88.79% (-2.6%)

Holders
1,055
Holders Change
+31
Holders Change %
+3.03%
% of All Funds
28.15%
Holding in Top 10
78
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+1.3%
% of All Funds
2.08%
New
79
Increased
384
Reduced
421
Closed
38
Calls
$233M
Puts
$174M
Net Calls
+$59M
Net Calls Change
+$99.8M
Name Holding Trade Value Shares
Change
Change in
Stake
BNP Paribas Financial Markets
426
BNP Paribas Financial Markets
France
$5.2M -$21.6M -146,311 -81%
GD
427
Grandfield & Dodd
New York
$5.16M -$55.3K -375 -1%
TCOV
428
Trust Company of Vermont
Vermont
$5.14M +$36.8K +249 +0.7%
PA
429
Pinnacle Associates
New York
$5.14M -$11.1K -75 -0.2%
LS
430
Livforsakringsbolaget Skandia
Sweden
$5.11M
GLRA
431
Gerald L. Ray & Associates
Texas
$5.07M -$73.8K -500 -1%
NEI
432
Northwest & Ethical Investments
Ontario, Canada
$4.97M -$4.85M -32,850 -49%
HKIM
433
Hayek Kallen Investment Management
Alabama
$4.95M -$139K -943 -3%
KRS
434
Kentucky Retirement Systems
Kentucky
$4.94M -$434K -2,942 -8%
MYAM
435
Meiji Yasuda Asset Management
Japan
$4.91M +$853K +5,777 +21%
NCM
436
Novare Capital Management
North Carolina
$4.89M -$7.38K -50 -0.2%
NLGIA
437
Nippon Life Global Investors Americas
New York
$4.87M +$4.87M +32,990 New
CIC
438
Chase Investment Counsel
Virginia
$4.83M -$347K -2,354 -7%
RHDIC
439
R.H. Dinel Investment Counsel
California
$4.83M
GI
440
GAMCO Investors
Connecticut
$4.81M -$25.8K -175 -0.5%
FFSOTS
441
Fiduciary Financial Services of The Southwest
Texas
$4.76M +$94.5K +640 +2%
DSC
442
Duncker Streett & Co
Missouri
$4.73M -$36.9K -250 -0.8%
B
443
Barings
North Carolina
$4.68M +$4.68M +31,689 New
TG
444
TCW Group
California
$4.68M +$125K +850 +3%
RCM
445
Riverhead Capital Management
Delaware
$4.67M -$4.8M -32,501 -51%
COPPSERS
446
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$4.66M +$310K +2,102 +7%
GIA
447
Gateway Investment Advisers
Ohio
$4.65M -$10.8K -73 -0.2%
BF
448
BOK Financial
Oklahoma
$4.54M -$1.79M -12,146 -28%
AC
449
Allstate Corporation
Illinois
$4.52M -$3.52M -23,831 -44%
CM
450
Churchill Management
California
$4.51M +$3.13M +21,218 +229%

TMO Hedge Fund Activity: Q2 2016 in Review

1,055 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2016, worth a combined $51.5B — up 5.3% from $48.9B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new TMO positions and 38 closed out — a net gain of 41 holders — while 384 added to existing stakes and 421 trimmed.

The largest buyer was Sound Shore Management, adding an estimated $180M. The largest seller was Royal London Asset Management, cutting an estimated $2.01B.

  • 1,055 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2016, up from 1,024 in Q1 2016.
  • Funds reported $51.5B of Thermo Fisher Scientific stock for Q2 2016, up 5.3% quarter-over-quarter.
  • 79 funds opened new Thermo Fisher Scientific positions in Q2 2016 and 38 closed out, a net change of +41 holders.
  • The largest Thermo Fisher Scientific buyer in Q2 2016 was Sound Shore Management, an estimated $180M added.
  • The largest Thermo Fisher Scientific seller in Q2 2016 was Royal London Asset Management, an estimated $2.01B sold.

Based on aggregated 13F filings for Q2 2016.